SE8700361L - Immunosuppressiva medel - Google Patents

Immunosuppressiva medel

Info

Publication number: SE8700361L
Authority: SE; Sweden
Prior art keywords: immunosuppressive agents; ergolines; quinolines; found; molecular weight
Prior art date: 1986-01-31

Application number

SE8700361A

Other languages

Unknown language ( )

English (en)

Swedish (sv)

Other versions

SE8700361D0 (sv

Inventor

D Larson

Original Assignee

Sandoz Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-01-31

Filing date

1987-01-30

Publication date

1987-08-01

1987-01-30 Application filed by Sandoz Ag filed Critical Sandoz Ag

1987-01-30 Publication of SE8700361D0 publication Critical patent/SE8700361D0/xx

1987-08-01 Publication of SE8700361L publication Critical patent/SE8700361L/

Links

229940125721 immunosuppressive agent Drugs 0.000 title 1
239000003018 immunosuppressive agent Substances 0.000 title 1
229940111121 antirheumatic drug quinolines Drugs 0.000 abstract 1
RHGUXDUPXYFCTE-ZWNOBZJWSA-N ergoline Chemical class C1=CC([C@@H]2[C@H](NCCC2)C2)=C3C2=CNC3=C1 RHGUXDUPXYFCTE-ZWNOBZJWSA-N 0.000 abstract 1
-1 ergolines Chemical class 0.000 abstract 1
230000001861 immunosuppressant effect Effects 0.000 abstract 1
150000003248 quinolines Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Transplantation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

SE8700361A 1986-01-31 1987-01-30 Immunosuppressiva medel SE8700361L (sv)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB868602372A GB8602372D0 (en)	1986-01-31	1986-01-31	Organic compounds

Publications (2)

Publication Number	Publication Date
SE8700361D0 SE8700361D0 (sv)	1987-01-30
SE8700361L true SE8700361L (sv)	1987-08-01

Family

ID=10592282

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE8700361A SE8700361L (sv)	1986-01-31	1987-01-30	Immunosuppressiva medel

Country Status (14)

Country	Link
EP (1)	EP0231151A3 (da)
JP (1)	JPS62190123A (da)
KR (1)	KR870007126A (da)
AU (1)	AU6812387A (da)
BE (1)	BE1002394A3 (da)
DE (1)	DE3701891A1 (da)
DK (1)	DK47687A (da)
FR (1)	FR2595571A1 (da)
GB (2)	GB8602372D0 (da)
IE (1)	IE870228L (da)
IT (1)	IT1216787B (da)
NL (1)	NL8700191A (da)
SE (1)	SE8700361L (da)
ZA (1)	ZA87712B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL8702680A (nl) *	1986-11-21	1988-06-16	Sandoz Ag	Nieuwe benzogchinolinen en werkwijzen voor het bereiden en toepassen van deze verbindingen.
EP0327040A3 (de) *	1988-02-05	1990-11-28	Predrag Dr.Sc. Sikiric	Verwendung von Dopamin und/oder von Dopamin-Agonisten zur Herstellung eines Arzneimittels für die Behandlung des Verdauungstrakts
BE1003009A5 (fr) *	1989-02-09	1991-10-22	Sandoz Sa	Nouvelles compositions pharmaceutiques a base de cyclosporines.
US5204329A (en) *	1990-06-11	1993-04-20	Du Pont Merck Pharmaceutical Company	Treatment of organ transplantation rejection
DE102005041613A1 (de) *	2005-09-01	2007-03-08	Ergonex Pharma Gmbh	Pharmazeutische Zusammensetzungen zur Behandlung von Karzinoid-Syndrom

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3867534A (en) *	1972-08-07	1975-02-18	Upjohn Co	Dosage regimen
US3928612A (en) *	1974-10-02	1975-12-23	American Home Prod	1,2-Dihydro- and 1,2,3,4-tetrahydro-1-oxo-3-isoquinolinecarboxylic acid derivatives as anti-allergic agents
US4225600A (en) *	1977-05-04	1980-09-30	Fisons Limited	Compositions and methods for treating certain skin conditions
CH632161A5 (it) *	1978-01-17	1982-09-30	Siphar Sa	Composizione farmaceutica per il trattamento dell'asma.
DE3247514A1 (de) *	1982-12-20	1984-06-20	Schering AG, 1000 Berlin und 4709 Bergkamen	Zytostatisch wirkende kombination
GB8422253D0 (en) *	1984-09-04	1984-10-10	Sandoz Ltd	Organic compounds

1986
- 1986-01-31 GB GB868602372A patent/GB8602372D0/en active Pending
1987
- 1987-01-23 DE DE19873701891 patent/DE3701891A1/de not_active Withdrawn
- 1987-01-23 EP EP87810040A patent/EP0231151A3/en not_active Withdrawn
- 1987-01-27 NL NL8700191A patent/NL8700191A/nl not_active Application Discontinuation
- 1987-01-28 GB GB08701847A patent/GB2185886A/en not_active Withdrawn
- 1987-01-29 AU AU68123/87A patent/AU6812387A/en not_active Abandoned
- 1987-01-29 FR FR8701180A patent/FR2595571A1/fr active Pending
- 1987-01-29 DK DK047687A patent/DK47687A/da not_active Application Discontinuation
- 1987-01-29 IE IE870228A patent/IE870228L/xx unknown
- 1987-01-30 KR KR870000800A patent/KR870007126A/ko not_active Ceased
- 1987-01-30 BE BE8700066A patent/BE1002394A3/fr active
- 1987-01-30 SE SE8700361A patent/SE8700361L/ not_active Application Discontinuation
- 1987-01-30 ZA ZA87712A patent/ZA87712B/xx unknown
- 1987-01-30 IT IT8747586A patent/IT1216787B/it active
- 1987-01-30 JP JP62021666A patent/JPS62190123A/ja active Pending

Also Published As

Publication number	Publication date
BE1002394A3 (fr)	1991-01-29
IT8747586A0 (it)	1987-01-30
GB2185886A (en)	1987-08-05
DK47687D0 (da)	1987-01-29
GB8701847D0 (en)	1987-03-04
NL8700191A (nl)	1987-08-17
IE870228L (en)	1987-07-31
GB8602372D0 (en)	1986-03-05
JPS62190123A (ja)	1987-08-20
EP0231151A3 (en)	1990-04-11
IT1216787B (it)	1990-03-14
AU6812387A (en)	1987-08-06
DK47687A (da)	1987-08-01
ZA87712B (en)	1988-09-28
KR870007126A (ko)	1987-08-14
SE8700361D0 (sv)	1987-01-30
DE3701891A1 (de)	1987-08-13
EP0231151A2 (en)	1987-08-05
FR2595571A1 (fr)	1987-09-18

Legal Events

Date

Code

Title

Description

1995-02-28

NAV

Patent application has lapsed

Ref document number: 8700361-2

Effective date: 19910801

Format of ref document f/p: F

Publication	Publication Date	Title
ATE232863T1 (de)	2003-03-15	Substituierte pyrido- oder pyrimidogruppen enthaltende 6,6- oder 6,7-bicyclische derivate
DE3776063D1 (en)	1992-02-27	Bryostatine.
DE3779563D1 (de)	1992-07-09	Reduzierte derivate von avermectin.
NO873842D0 (no)	1987-09-14	Baerekonstruksjon for bord.
DE3769191D1 (de)	1991-05-16	Cycloalkano(1,2-b)indol-sulfonamide.
ATE63110T1 (de)	1991-05-15	Farblose ketimine, ihre herstellung und ihre verwendung als vernetzungsmittel.
DE3870959D1 (de)	1992-06-17	2-difluormethoxy-1,1,1,2-tetrafluoraethan als anaesthetikum.
IT1203945B (it)	1989-02-23	Agenti stabilizzanti costituiti da 1,3,2-ossazafosfolidine
DE68918802D1 (de)	1994-11-17	Stickstoff enthaltende heterozyklische Derivate.
DE3778365D1 (de)	1992-05-21	Entzuendungshemmende mittel.
FI881984L (fi)	1988-10-31	Terminala polyvinylfunktionala makromerer, polymerer daerav och kontaktlinser framstaellda daerav.
DK539285D0 (da)	1985-11-21	Immunosuppressiv faktor
DE3863191D1 (de)	1991-07-18	Substituierte aminderivate, ihre herstellung und verwendung.
DE3764192D1 (de)	1990-09-13	Schmiermittel und polyfluorierte verbindungen, verwendbar als zusaetze.
DE3779358D1 (de)	1992-07-02	Pyrido(2,3-b)indole.
ES2022263B3 (es)	1991-12-01	Apoyo deslizante.
SE8700361D0 (sv)	1987-01-30	Immunosuppressant agents
DE3774347D1 (de)	1991-12-12	Sechsgliedrige heterocyclische derivate von n'-substituierten n,n'-diacylhydrazinen.
NO883070D0 (no)	1988-07-08	4-aminosubstituerte 1,2-dihydroksynaftalin-derivater.
DE3783111D1 (de)	1993-01-28	Fuenfgliedrige heterocyclische derivate von n'-substituierten n,n'-diacylhydrazinen.
ATE45164T1 (de)	1989-08-15	Steroido(3,2-c>-pyrazole, als antiandrogene und ihre herstellung.
DE58903514D1 (de)	1993-03-25	Derivate der 2,3-difluorbenzoesaeure.
DE3873278D1 (de)	1992-09-03	Aryl-substituierte thiophen-3-ole, ihre derivate und analoge als lipoxygenase-inhibitoren.
IT8621397A0 (it)	1986-08-01	Derivati del pirrolidin-2-one adattivita' nootropa.
ES2060944T3 (es)	1994-12-01	Derivados de 2,5,6,7-tetranor-4,8-inter-m-fenileno de pgi2 (prostaglandina i2).